Skip to content
My WebMD Sign In, Sign Up

Which Hemophilia Treatment Approach Is Best for My Child?

Reviewed by Brenda Riske, RN, MS, MBA, MPA

|Disclosures|Published on May 29, 2015
 

 
 

Developed through a strategic collaboration with the National Hemophilia Foundation.

 

References

  1. Powell JS, Pasi KJ, Ragni MV, Ozelo MC, Valentino LA, Mahlangu JN, et al. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. NEJM. 2013;369:2313-23.

  2. Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, et al. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A. Blood. 2014;123:317-25.

  3. Collins PW, Young G, Knobe K, et al. Paradigm 2 Investigators. Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial. Blood. 2014;124:3880-3886.

  4. National Institutes of Health. National Heart, Lung, and Blood Institute. How is hemophilia treated? http://www.nhlbi.nih.gov/health/health-topics/topics/hemophilia/treatment. Accessed April 23, 2015.

Authors and Disclosures

Author(s)

Brenda Riske, RN, MS, MBA, MPA

Director of Strategic Operations, Hemophilia and Thrombosis Center, University of Colorado, Aurora, Colorado

Disclosure: Brenda Riske, RN, MS, MBA, MPA, has disclosed the following relevant financial relationships:
Served as a member of grants review committee: Bayer HealthCare Pharmaceuticals

Ms. Riske does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Ms. Riske does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Stacey J. P. Ullman, MHS

Scientific Director, Medscape, LLC

Disclosure: Stacey J. P. Ullman, MHS, has disclosed no relevant financial relationships.

Kim L. Farina, PhD

Principal, BenMedComm Health and Medical Communications, Houston, Texas

Disclosure: Kim L. Farina, PhD, has disclosed no relevant financial relationships.

Additional Planners/Reviewers

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Print
URAC: Accredited Health Web Site HonCode: Health on the Net Foundation AdChoices